glp 1 drugs contraindications GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms I'm seeing where this is

As typical for retrospective chart reviews, the outcome variables were limited to those that were systemically recorded on the patient charts during routine clinical outpatient visits, resulting in that some tests ( e.g

patients had CKD stages 1 to 5 diagnosed by Kidney Disease: Improving Global Outcomes guidelines plus at least 3 months of one of the following: moderate to severe albuminuria regardless of estimated glomerular filtration rate (eGFR), eGFR less than 90 mL/min/1.73 m 2 with structural abnormalities of the kidney or urinary sediment abnormalities, or eGFR less than 60 mL/min/1.73 m 2 Efficacy End Points: Reduction in all-cause death, major adverse cardiovascular events (composite outcomes), and cardiovascular death

If not for this compound, the body cell cannot detoxify properly and there is a high likelihood of cell damage

No sulfates